FindTrial
Sign In

Balstililmab

DRUG2 trials

Sponsors

Agenus Inc., Nelum Corp

Conditions

Advanced Pancreatic CancerColorectal Cancer (CRC)Hepatocellular Carcinoma (HCC)MelanomaNon-Small Cell Lung Cancer (NSCLC)Ovarian CancerPancreatic CancerProstate Cancer

Phase 2

A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.
Not yet recruitingNCT07578337
Nelum CorpAdvanced Pancreatic Cancer, Untreated
Start: 2026-07-15End: 2029-02-28Target: 40Updated: 2026-05-13

Unknown Phase

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
NCT06751524
Agenus Inc.Colorectal Cancer (CRC), Hepatocellular Carcinoma (HCC), Melanoma +5
Updated: 2026-05-15